- KOREAN
- P-ISSN3022-6805
- E-ISSN3022-6791
- KCI
ISSN : 3022-6805
Management of Psoriasis through Unani Medicine: a Case Study
Qamar Uddin (Department of Moalajat (Medicine), National Research Institute of Unani Medicine for Skin Disorders (NRIUMSD))
Arzeena Jabeen (Department of Moalajat (Medicine), National Research Institute of Unani Medicine for Skin Disorders (NRIUMSD))
Mohd Azahar (Department of Moalajat (Medicine), National Research Institute of Unani Medicine for Skin Disorders (NRIUMSD))
Md Aftab Alam (Department of Ilmul Advia (Pharmacology), National Research Institute of Unani Medicine for Skin Disorders (NRIUMSD))
Abdul Munim (Department of Moalajat (Medicine), National Research Institute of Unani Medicine for Skin Disorders (NRIUMSD))
Abstract
Psoriasis is a chronic inflammatory skin disease clinically characterized by erythematous, sharply demarcated papules and rounded plaques covered by silvery white micaceous scales. It affects about 1-3% of the world’s population. Although considerable advances have been made in the management of psoriasis in recent years, the disease remains incurable. Current treatment does not affect disease activity, and relapse occurs quickly after cessation of treatment. Moreover, topical and systemic conventional therapies used in the management of psoriasis are associated with adverse effects. In Unani system of medicine, psoriasis is known as Taqashshur al-Jild, which is caused by predominance of black bile and characterised by scaling of skin. Various topical as well as systemic Unani formulations are effectively used in the management of psoriasis. This case study was aimed to evaluate the efficacy of Unani formulations, Itrīfal Shāhtra and Marham Ḥinā in the management of psoriasis. A 49-year-old male patient presenting with psoriasis came to the OPD of National Research Institute of Unani Medicine for Skin Disorders, Hyderabad. Treatment was given to the patient for a period of 12 weeks. PASI score was significantly reduced from 40.5 at baseline to 2.2 after treatment. Unani formulations were found safe and effective in the management of Psoriasis as assessed by validated scales.
- keywords
- Psoriasis, Taqashshur al-Jild, Unani, Itrīfal Shāhtra, Marham Ḥinā, PASI
Reference
Ali H, Aslam M, Sofi G. Unani Management of Taqashshure Jild (Psoriasis): A case report. Sch J Appl Med Sci. 2015; 3(2B):677-681.
Āmlī, Muḥammad ibn Maḥmūd. Mūjaz. (Lucknow, India:Maṭba‘Munshī Naval Kishore), p. 219, 1304
Hijri. Anonymous. National Formulary of Unani Medicine, Part-VI. (New Delhi, India: CCRUM, Dept. of AYUSH, Ministry of Health & Family Welfare, Govt. of India), p. 78, 2011.
Arzānī, Ḥakīm Muḥammad Akbar. Mīzān al-Ṭibb. Urdu translation by Ḥakīm Muḥammad Kabīr al-Dīn. (New Delhi:Idārā Kitāb al-Shifā), p. 257, 2001.
Arzānī, Ḥakīm Muḥammad Akbar. Ṭibb-i-Akbar. Translated by Hussain HM. (Deoband, India: Faisal Publications), pp. 739-742, 1993.
Baghdādī, ‘Ali ibn Hubal. Kitāb al-Mukhtārāt fi’l Ṭibb. Urdu translation. Volume 2. (New Delhi, India: CCRUM, Ministry of Health & Family Welfare, Govt. of India), pp. 83,189-190, 2005.
Burge S, Matin R, Wallis D. Oxford Handbook of Medical Dermatology. 2nd Edn. (UK: Oxford University Press), pp. 189-209, 2016.
Buslau M & Benotmane K. Cardiovascular complications of psoriasis: Does obstructive sleep apnoea play a role? Acta Derm Venereol. 1999; 79(3):234.
Carvalho AVE, Romiti R, Souza CS, Paschoal RS, Milman LM, Meneghello LP. Psoriasis comorbidities: complications and benefits of immunobiological treatment. An Bras Dermatol. 2016; 91(6):781-789.
Danielsen K, Olsen AO, Wilsgaard T, Furberg AS. Is the prevalence of psoriasis increasing? A 30-year follow-up of a population-based cohort. Br J Dermatol. 2013; 168:1303-1310.
DiPiro JT, Yee GC, Posey LM, Haines ST, Nolin TD, Ellingrod VL. Pharmacotherapy: A Pathophysiologic Approach. 11th Edn. (New York, USA: McGraw-Hill Education), pp. 4772-4841, 2020.
Dreiher J, Weitzman D, Shapiro J, Davidovici B, Cohen AD. Psoriasis and chronic obstructive pulmonary disease: A casecontrol study. Br J Dermatol. 2008; 159(4):956-960.
Gelfand JM, Shin DB, Neimann AL, Wang X, Margolis DJ, Troxel AB. The risk of lymphoma in patients with psoriasis. J Invest Dermatol. 2006; 126(10):2194-2201.
Gibbs S. Skin disease and socioeconomic conditions in rural Africa: Tanzania. Int J Dermatol. 1996; 35(9):633-639.
Gisondi P, Targher G, Zoppini G, Girolomoni G. Nonalcoholic fatty liver disease in patients with chronic plaque psoriasis. J Hepatol. 2009; 51(4):758-764.
Ibn Zuhr. Kitāb al-Taysīr. Urdu translation. (New Delhi, India:CCRUM, Ministry of Health & Family Welfare, Govt. of India), pp. 204-205, 1986.
Jīlānī, Ḥakīm Ghulām. Makhzan al-Ḥikmat. (New Delhi, India:Ejaz Publishing House), pp. 698-699, 1996.
Khān, Ḥakīm Muḥammad A‘ẓam. Iksīr-i-A‘ẓam (Fārsī). (Kanpur, India: Maṭba‘ Niẓāmī), p. 511, 1289
Hijri. Khān, Ḥakīm Muḥammad Akmal. Qarābādīn-ī ‘Āzam wa Akmal. Urdu Translation. (New Delhi, India: CCRUM, Dept. of AYUSH, Ministry of Health & Family Welfare, Govt. of India), p. 7, 2005.
Majūsī, ‘Ali ibn ‘Abbās. Kāmil al-Ṣanā‘a al-Ṭibbiyya. Urdu translation by Ḥakīm Ghulām Ḥasnayn Kintūrī. Volume I-II. (New Delhi, India: Idārā Kitāb al-Shifā), pp. 431-433, 2010.
Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies. J Am Acad Dermatol. 2009; 60(4):643-659.
Millard TP, Antoniades L, Evans AV, Smith HR, Spector TD, Barker JN. Bone mineral density of patients with chronic plaque psoriasis. Clin Exp Dermatol. 2001; 26(5):446-448.
Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med. 2009; 361(5):496-509.
Nickoloff BJ, Wrone-Smith T, Bonish B, Porcelli SA. Response of murine and normal human skin to injection of allogeneic blood-derived psoriatic immunocytes: detection of T cells expressing receptors typically present on natural killer cells, including CD94, CD158, and CD161. Arch Dermatol. 1999; 135(5):546-52.
Papadakis MA, McPhee SJ, Rabow MW. Current Medical Diagnosis & Treatment. 58th Edn. (US: McGraw-Hill Education), pp. 115-117, 2019.
Peternel S, Prpić-Massari L, Guina T, Novak S, Brajac I, Kastelan M. Treatment of Severe Psoriasis with Infliximab:Report of Two Cases. Acta Dermatovenerol Croat. 2009; 17(3):204-206.
Qarshī, Ḥakīm Muḥammad Ḥasan. Jame-ul-Ḥikmat. Vol. 2.(Delhi, India: Idārā Kitāb al-Shifā), p. 1005, 2011.
Rahman M, Alam K, Ahmad MZ, Gupta G, Afzal M, et al. Classical to current approach for treatment of psoriasis: a review. Endocr Metab Immune Disord Drug Targets. 2012; 12(3):287-302.
Rāzī, Abū Bakr Muḥammad ibn Zakariyya. Kitāb al-Fākhir fi’l Ṭibb (Arabic). Part-1. (New Delhi, India: CCRUM, Ministry of Health & Family Welfare, Govt. of India), pp. 28, 46, 2005.
Rāzī, Abū Bakr Muḥammad ibn Zakariyya. Kitāb al-Ḥāwī fi’l Ṭibb (Urdu translation by Ḥakīm MY Ṣiddīquī). Vol-23. (Aligarh, India: Saba Publishers), pp. 61-62, 1994.
Rāzī, Abū Bakr Muḥammad ibn Zakariyya. Kitāb al-Manṣūrī. Urdu translation. (New Delhi, India: CCRUM, Ministry of Health & Family Welfare, Govt. of India), p. 200, 1991.
Sehgal, VN. Textbook of Clinical Dermatology. 5th Edn. (New Delhi, India: Jitendar P Vij, Jaypee Brothers Medical Publishers), pp. 135-148, 2011.
Sheu JJ, Wang KH, Lin HC, Huang CC. Psoriasis is associated with an increased risk of parkinsonism: a population-based 5-year follow-up study. J Am Acad Dermatol. 2013; 68(6):992-999.
Ṭabarī, Abu’l Ḥasan Aḥmad ibn Muḥammad. Mu‘ālajāt alBuqrāṭiyya (Urdu translation). Vol-2. (New Delhi, India:CCRUM, Ministry of Health & Family Welfare, Govt. of India), pp. 153-155, 1997.
Valia RG & Valia AR. IADVL Textbook of Dermatology. 3rd Edn. Vol. 1. (Mumbai, India: Bhalani Publishing House), pp. 1025-1055, 2010.
- Downloaded
- Viewed
- 0KCI Citations
- 0WOS Citations